Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.58 - $1.3 $205,655 - $460,952
354,579 Added 32.88%
1,432,918 $1.48 Million
Q1 2023

May 15, 2023

BUY
$1.09 - $1.82 $344,486 - $575,198
316,043 Added 41.46%
1,078,339 $1.47 Million
Q4 2022

Feb 14, 2023

BUY
$1.52 - $3.39 $19,779 - $44,114
13,013 Added 1.74%
762,296 $1.17 Million
Q3 2022

Nov 14, 2022

BUY
$1.7 - $4.05 $83,670 - $199,332
49,218 Added 7.03%
749,283 $2.19 Million
Q2 2022

Aug 15, 2022

BUY
$1.6 - $5.07 $115,289 - $365,323
72,056 Added 11.47%
700,065 $1.3 Million
Q1 2022

May 16, 2022

BUY
$3.92 - $5.86 $1 Million - $1.5 Million
255,928 Added 68.78%
628,009 $2.74 Million
Q4 2021

Feb 14, 2022

BUY
$5.0 - $14.85 $116,140 - $344,935
23,228 Added 6.66%
372,081 $2.01 Million
Q3 2021

Nov 12, 2021

BUY
$12.13 - $16.99 $4.23 Million - $5.93 Million
348,853 New
348,853 $4.79 Million

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.